Trending Now
Commercial Special Features

Day Two Recap of the LF Dealmakers Conference

October 1, 2021

Day Two Recap of the LF Dealmakers Conference

Day two of of the two-day event saw a trio of panels that covered topics such as investment strategy and risk management, the interplay between fund types, and litigation finance as a tool for ESG. The first panel of the day was titles “CIO Roundtable: Focus on Investment Strategy & Risk Management,” and was moderated by Steven Molo, Founding Partner of MoloLamken. Panelists included:
  • Patrick Dempsey, Chief Investment Officer, US, Therium Capital
  • Sarah Johnson, Co-Head Litigation Finance, The D. E. Shaw Group
  • Aaron Katz, Chief Investment Officer, Parabellum Capital
  • David Kerstein, Chief Risk Officer & Senior Investment Manager, Validity Finance
The conversation began with the rise of business interruption claims. Patrick Dempsey of Therium hasn’t seen much in the way of business interruption claims that have been successful yet.  There was an initial interest in this case type, but then a lot of negative decisions came out of federal courts, and so interest waned. That said, you can build a portfolio of these claims and hedge your risk going forward. Aaron Katz of Parabellum noted how his firm hasn’t been active in the business interruption space, though the pace of all other claim types is picking up, with interesting new product areas being developed, including credit-like structures, different stages of cases being presented, lower risk investment types, and even partial recourse feature investment. Sarah Johnson of D.E. Shaw commented on the emergence of new entrants into the litigation funding space. Competition does affect pricing, and this has more of an impact in creative structuring—with new tranches of risk being created. David Kerstein of Validity jumped in to parse this out. He has seen more competition in pricing in larger size deals, however not so much in the more modestly-sized deals. There is still competition there, as claimants are approaching a lot of funders, just not as much price pressure in these types of claims. The conversation then turned to bankruptcy. This was a very quick distressed cycle—given that there was a lot of sophisticated money chasing these deals, there wasn’t as much of a need for litigation funding. However, we may soon begin to see bankruptcies driven by litigation, which could prompt claimants to approach funders for partnership or monetization. And smaller cases might be a place for funders, given that these bankruptcy claims are typically underfunded. As David Kerstein of Validity noted, “When there are bankruptcies that are based on litigation assets or issues, litigation funders are well placed to come in and provide value.” And on the issue of insurance, Aaron Katz noted that judgments are being protected with insurance, products are out there to preserve capital or even back some of the profit in a deal. That said, Parabellum hasn’t seen it as part of the bread and butter of their work. Yet Katz feels it’s only a matter of time before insurance permeates the space, but we’re not there yet. Patrick Dempsey chimed in on his experience with insurance in UK-based claims. Adverse costs insurance is inherent in the jurisdiction there, and so insurance on a portfolio basis was being considered very early on. That was ultimately deemed unnecessary, but that discussion is starting to return, and will likely come back in full force. Therium only uses insurance for judgment protection in the U.S. On the issue of regrets, Sarah Johnson noted how she wishes she had been more aggressive at the outset—doing more deals, and being less price sensitive. Having worked previously in distressed investments, she was used to price sensitivity being an issue, but she found that the industry grew a lot faster and provided much better returns than perhaps even she expected. This speaks well to the industry’s continued growth potential. Later in the day, a pair of panels tackled topics such as fund types, deal structures and costs of capital, as well as ESG and impact investing. One interesting takeaway from the former discussion came from Sarah Lieber, Managing Director and Co-Head of the Finance Group at Stifel. Lieber commented on the large commercial bank syndication model that her firm is structured with. What Stifel does is essentially a merchant banking model—they use their own balance sheet and originate their own transactions. When they approach a partner, whether that is a litigation funder, insurance company, private equity or multi-strategy firm, they choose their partner based on the return profile. And they can syndicate their partnerships within a larger deal construct. Stifel generally operates in the $50MM+ range, and can take on multiple co-investors with various tranches. So Stifel operates in cooperation with many other in the space, in a syndicated investment model. Stifel’s very presence in the market is emblematic of how prominent the funding industry has grown, and how much it has matured over the past few years. Doubtless there will be further maturation ahead, and likely more funding entities which enact a similar merchant banking model. As Tets Ishikawa Managing Director of LionFish noted (on the same panel discussion): “When the market started in the last 15-20 years, it really started as a litigation funding industry—as one single entity. But I believe this market will become like the commercial real estate market. There are many different types of real estate, just as there are many different types of litigation, so in the end there will be many different types of litigation finance investors.”

Commercial

View All
Commercial People Moves

Red Lion Chambers Hires Former Harbour Director for Client Role

By John Freund |

Red Lion Chambers has taken a notable step in strengthening its engagement with litigation funders and commercial clients by appointing a former senior figure from the funding industry into a newly created client-facing role. The move reflects the increasingly close relationship between the UK Bar and third-party litigation finance, particularly in complex commercial and group actions where funding strategy and legal execution are closely intertwined.

An article in Global Legal Post reports that Red Lion Chambers has appointed James Hartley, formerly a director at Harbour Litigation Funding, as its first director of client relationships. In this newly established position, Hartley will be responsible for developing relationships with solicitors, funders, and other clients, as well as helping to align the chambers’ barristers with funded opportunities across commercial litigation, arbitration, and competition claims.

Hartley brings several years of experience from the funding side of the market, having worked at Harbour Litigation Funding where he was involved in evaluating claims, structuring funding arrangements, and working closely with law firms and counsel on strategy. His move to Red Lion Chambers underscores the value chambers are placing on individuals who understand both the legal and financial dynamics of funded disputes, as well as the commercial drivers behind claim selection and case management.

According to the report, Red Lion Chambers sees the appointment as part of a broader effort to modernise how barristers’ chambers engage with the market, particularly as clients and funders increasingly expect a more coordinated and commercially aware approach from counsel. The role is intended to complement, rather than replace, the traditional clerking function, with a specific focus on strategic relationships and long-term growth areas.

Case Developments Commercial

Longford Capital and Susman Godfrey Sued Over $32m Arbitration Award

By John Freund |

A new lawsuit has placed litigation funder Longford Capital Corp and prominent US trial firm Susman Godfrey LLP at the center of a high-stakes dispute over the ownership and allocation of arbitration proceeds, highlighting the growing complexity and occasional friction in funded litigation arrangements. The case stems from a roughly $32 million arbitration award tied to patent litigation recoveries and raises questions about the enforceability of funding agreements, arbitration clauses, and the definition of recoverable proceeds.

An article in Reuters reports that the lawsuit was filed in Texas state court by Arigna, an Ireland-based patent monetization company that previously worked with Susman Godfrey to pursue semiconductor-related patent claims. Arigna alleges that it was improperly forced into arbitration and that the resulting award in favor of Longford was tainted by arbitrator misconduct. According to the complaint, Arigna is seeking to have the arbitration award vacated and to recover approximately $5.5 million in settlement funds currently held in escrow.

The dispute traces back to a funding arrangement entered into after Arigna retained Susman Godfrey to pursue patent enforcement actions. Susman subsequently secured third-party litigation financing from Longford Capital. Tensions emerged over how Longford’s entitlement to proceeds should be calculated, particularly in relation to settlements involving multiple defendants and intellectual property assets that Arigna claims were outside the scope of the original funding deal. An earlier federal court battle over whether the dispute belonged in court or arbitration ultimately resulted in the matter being sent to arbitration, where the arbitrator ruled in Longford’s favor.

Now, Arigna argues that the arbitration should never have occurred and that Longford and Susman overreached in asserting rights to settlement proceeds. Longford has defended the award as valid and enforceable, while Susman Godfrey is also named as a defendant due to its role in structuring and executing the underlying legal and funding arrangements.

Case Developments Commercial

LitFin Backs €250m Antitrust Claims for Farmers

By John Freund |

LitFin, the Prague-headquartered litigation financier, has reached a major procedural milestone in one of Europe’s largest coordinated private antitrust actions, backing claims on behalf of more than 1,700 agricultural businesses harmed by a long-running pesticide cartel in Germany. In December 2025, damages claims approaching €250 million, including interest, were formally filed against wholesale distributors of plant protection products found to have engaged in unlawful price-fixing over nearly two decades.

LitFin reports that the claims are grounded in binding findings by Germany’s Federal Cartel Office, which determined that cartel conduct spanned from 1998 to 2015 and covered almost the entire market for plant protection products. That infringement resulted in administrative fines totaling approximately €157 million. Under German and EU competition law, such findings create a strong presumption that purchasers paid unlawful price surcharges during both the cartel period and its after-effects—forming the economic basis of the damages now being pursued by affected farmers.

The lawsuit has been filed by WAGNER LEGAL Rechtsanwälte PartG mbB, a Hamburg-based firm specializing in antitrust damages litigation, working in close coordination with the funder. According to LitFin, the claims are supported by a comprehensive economic analysis prepared by competition experts at Charles River Associates, quantifying the alleged overcharges suffered by claimants across the German agricultural sector.

For the agricultural businesses involved, the filing represents more than just a legal step forward. Without third-party funding, coordinating and prosecuting claims of this scale against well-resourced defendants would likely have been impractical. LitFin’s involvement enabled aggregation of claims, risk-sharing, and the deployment of specialist legal and economic expertise across a complex, multi-claimant proceeding.